Sponsor

Cliniques Universitaires Saint-Luc

Belgium Hippokrateslaan 10, Batiment 54, 1200 Woluwe-Saint-Lambert, Belgium

About the sponsor

Clinical research includes Alzheimer's disease and related cognitive disorders, with a focus on PET/CT imaging of tau and amyloid pathology in the brain.

Alzheimer's disease
mild cognitive impairment
neuroimaging biomarkers

Work in this area also covers comparison with control populations to characterise regional protein deposition patterns across neurodegenerative conditions.

About Specializations

Cliniques Universitaires Saint-Luc runs clinical trials in conditions such as Dementia Alzheimer's type, Clear cell renal cell carcinoma, Rheumatoid arthritis, Head and neck cancer, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

8 clinical trials

Dementia Alzheimer's type

Recruiting

Study on Brain Imaging for Alzheimer's Disease Using Florquinitau (18F) in Patients with Mild Cognitive Impairment and Early Alzheimer's Symptoms

InvestigationalNo placebo

Study on Brain Imaging for Alzheimer's Disease Using Florquinitau (18F) in Patients with Mild Cognitive Impairment and Early Alzheimer's Symptoms

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Florquinitau (18F)
Sponsor:Cliniques Universitaires Saint-Luc

Contact Research Centre

Clear cell renal cell carcinoma

Recruiting

Study on the Effectiveness of Early PSMA-PET Scans with Gozetotide in Patients with Metastatic Renal Cancer Undergoing Standard Immunotherapy

Registered drugNo placebo

Study on the Effectiveness of Early PSMA-PET Scans with Gozetotide in Patients with Metastatic Renal Cancer Undergoing Standard Immunotherapy

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Gozetotide
Sponsor:Cliniques Universitaires Saint-Luc

Contact Research Centre

Rheumatoid arthritis

Recruiting

Study of Sarilumab for Patients with Rheumatoid Arthritis Not Responding to Anti-TNF Therapy

Registered drugNo placebo

Study of Sarilumab for Patients with Rheumatoid Arthritis Not Responding to Anti-TNF Therapy

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Sarilumab
Sponsor:Cliniques Universitaires Saint-Luc

Contact Research Centre

Head and neck cancer

Not yet recruiting

Study of ezabenlimab in patients with locally advanced head and neck cancer who have remaining signs of disease after chemoradiotherapy

InvestigationalNo placebo

Study of ezabenlimab in patients with locally advanced head and neck cancer who have remaining signs of disease after chemoradiotherapy

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Ezabenlimab
Sponsor:Cliniques Universitaires Saint-Luc

Contact Research Centre

Arteriovenous malformation

Not yet recruiting

Study on the Safety and Effectiveness of Regorafenib for Patients with Arterio-Venous Malformations Unresponsive to Standard Treatment

Registered drugNo placebo

Study on the Safety and Effectiveness of Regorafenib for Patients with Arterio-Venous Malformations Unresponsive to Standard Treatment

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Regorafenib
Sponsor:Cliniques Universitaires Saint-Luc

Contact Research Centre

Cardiac sarcoidosis

Not yet recruiting

Detecting Heart Inflammation in Cardiac Sarcoidosis Patients Using 68Ga-NOTA-Anti-MMR-VHH2 PET-CT Imaging

InvestigationalNo placebo

Detecting Heart Inflammation in Cardiac Sarcoidosis Patients Using 68Ga-NOTA-Anti-MMR-VHH2 PET-CT Imaging

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Nanobody Against Macrophage Mannose Receptor, Conjugated With 1,4,7-Triazacyclononane-N,N',N''-Triacetic Acid, Labelled With Gallium Ga-68
Sponsor:Cliniques Universitaires Saint-Luc